An increasing number of proteins involved in genome organization have been implicated in neurodevelopmental disorders, highlighting the importance of chromatin architecture in the developing CNS. The CCCTC-binding factor (CTCF) is a zinc finger DNA binding protein involved in higher-order chromatin organization, and mutations in the human CTCF gene cause an intellectual disability syndrome associated with microcephaly. However, information on CTCF function in vivo in the developing brain is lacking. To address this gap, we conditionally inactivated the Ctcf gene at early stages of mouse brain development. Cre-mediated Ctcf deletion in the telencephalon and anterior retina at embryonic day 8.5 triggered upregulation of the p53 effector PUMA (p53 upregulated modulator of apoptosis), resulting in massive apoptosis and profound ablation of telencephalic structures. Inactivation of Ctcf several days later at E11 also resulted in PUMA upregulation and increased apoptotic cell death, and the Ctcf-null forebrain was hypocellular and disorganized at birth. Although deletion of both Ctcf and Puma in the embryonic brain efficiently rescued Ctcf-null progenitor cell apoptosis, it failed to improve neonatal hypocellularity due to decreased proliferative capacity of rescued apical and outer radial glia progenitor cells. This was exacerbated by an independent effect of CTCF loss that resulted in depletion of the progenitor pool due to premature neurogenesis earlier in development. Our findings demonstrate that CTCF activities are required for two distinct events in early cortex formation: first, to correctly regulate the balance between neuroprogenitor cell proliferation and differentiation, and second, for the survival of neuroprogenitor cells, providing new clues regarding the contributions of CTCF in microcephaly/intellectual disability syndrome pathologies.
Introduction
CTCF is a multifunctional DNA binding protein that regulates higher-order chromatin structure to influence transcriptional regulation, genomic imprinting, X chromosome inactivation, and chromatin insulation (Holwerda and de Laat, 2013) . It binds to a variety of highly divergent target sequences throughout the genome using a combination of its 11 zinc finger motifs (Nakahashi et al., 2013) . CTCF partners with a number of chromatinrelated proteins such as the cohesin complex (Parelho et al., 2008; Wendt et al., 2008) , nucleophosmin, and CTCF itself (Yusufzai and Felsenfeld, 2004; Yusufzai et al., 2004) . These interactions may allow CTCF sites to contact one another and/or to be tethered to subnuclear domains. CTCF-mediated chromatin interactions detected by Chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) correlate with ϳ10% of all CTCF binding sites (CBSs), however, indicating that CTCF likely plays additional roles within the cell (Handoko et al., 2011) .
De novo mutations in CTCF have been identified previously in patients with varying degrees of intellectual disability and microcephaly (Gregor et al., 2013) , highlighting the importance of chromatin organization for the normal development and function of the CNS. Whereas CTCF function has been studied extensively in cell culture systems, its function in an in vivo context remains to be completely resolved (Ohlsson et al., 2010) . Ubiquitous deletion of CTCF in the mouse leads to lethality before embryonic day 3.5 (E3.5), suggesting that it is essential for early developmental processes (Fedoriw et al., 2004; Heath et al., 2008; Moore et al., 2012) . Conditional deletion of Ctcf in specific tissues causes either reduced proliferation or apoptotic cell death, depending on the tissue targeted for Cre recombination. For example, deletion of Ctcf in thymocytes resulted in increased p21 and p27 expression and cell cycle arrest, whereas reduced CTCF in mouse oocytes induced meiotic and mitotic defects and apoptotic cell death before the blastocyst stage (Fedoriw et al., 2004; Heath et al., 2008; Wan et al., 2008) . Deletion of Ctcf in the developing limb bud resulted in massive apoptosis and nearcomplete loss of limb structures, accompanied by increased p53 upregulated modulator of apoptosis (PUMA), a known activator of caspase-mediated apoptosis (Nakano and Vousden, 2001; Yu et al., 2001; Soshnikova et al., 2010) . In human cancer cells, CTCF binds to the Puma gene, and its depletion results in increased Puma transcript and rapid apoptosis, indicating that Puma transcription can be directly influenced by the presence or absence of CTCF (Gomes and Espinosa, 2010a,b) .
Given the deleterious effects of CTCF mutations in the human CNS, we specifically inactivated Ctcf in the developing mouse brain. CTCF loss of function using two different Cre driver lines in mice triggered apoptosis in dividing neuroprogenitor cells (NPCs) of the forebrain. Despite prevention of apoptosis by Puma deletion, rescued Ctcf/Puma double-null apical and outer radial glia (oRG) progenitors exhibited decreased proliferative capacity. Furthermore, loss of CTCF caused premature neurogenesis, resulting in depletion of the progenitor pool and a microcephaly phenotype at birth. These findings highlight the complexity of CTCF activities during neurogenesis.
Materials and Methods
Mouse husbandry and genotyping. Mice were exposed to 12 h light/dark cycles and fed tap water and regular chow ad libitum. The Ctcf loxP mice, in which loxP sites flank exons 3-12, have been described previously (Heath et al., 2008) . Mice conditionally deficient in CTCF were generated by crossing Ctcf loxP/ϩ females (C57BL/6 background) with heterozygous Foxg1Cre knock-in male mice (129/sv background) or with NestinCre heterozygous male mice (C57BL/6 background; Hébert and McConnell, 2000; Bérubé et al., 2005 Villunger et al., 2003) . DNA from tail biopsies of newborn pups or yolk sac from embryos was genotyped by PCR. Primer sequences are provided in Table 1 .
Immunostaining and histology. For immunofluorescence staining, cryosections were incubated with the primary antibody overnight at 4°C, washed in PBS/0.3% Triton-X 100, and incubated with the secondary antibody for 1 h. Sections were counterstained with DAPI (SigmaAldrich) and mounted in SlowFade Gold (Invitrogen). Primary antibodies used were as follows: rabbit anti-CTCF (1:400; Cell Signaling Technology), rabbit anti-cleaved caspase 3 (AC3; Asp175; 1:400; Cell Signaling Technology), mouse anti-BrdU as follows: goat-anti-rabbit Alexa 594 (1:800; Invitrogen), goat-antimouse Alexa 488 (1:800; Invitrogen), donkey-anti-sheep Alexa 594 (1: 800; Invitrogen), and donkey-anti-mouse Alexa 488 (1:800; Invitrogen). Sections were subjected to antigen retrieval (incubated in 0.1 mM sodium citrate, pH 6.0, heated to ϳ95°C and microwaved on low for 10 min) before overnight incubation (for BrdU, SOX2, PAX6, TBR2, STAB2, TBR1, and CTIP2). Terminal deoxynucleotidyl nick end labeling (TUNEL) was performed according to the manufacturer's instructions (Roche). For histological studies, slides were stained with hematoxylin and eosin (H&E).
BrdU labeling. Pregnant mice were injected intraperitoneally with cell proliferation labeling reagent [10 mM bromodeoxyuridine (BrdU) and 1 mM fluorodeoxyuridine (FdU) in H 2 O] at 1 ml/100 g body weight, or 0.3 mg/g body weight (GE Healthcare Life Sciences). Animals were killed after 1 h by CO 2 asphyxiation, and the embryos were recovered in icecold PBS, pH 7.4, and were fixed in 4% paraformaldehyde. Tissue was equilibrated in 30% sucrose/PBS and frozen in OCT (Tissue Tek). For cell cycle exit analysis, pregnant female mice (E13) were injected with cell proliferation labeling reagent at 1 ml/100 g body weight (GE Healthcare Life Sciences), and embryos were collected and processed for immunofluorescence analysis 24 h later. Before immunofluorescence analysis, cryosections (8 m) were treated with 2N HCl to denature the DNA, and neutralized with 0.1 M Na 2 B 4 O 7 , pH 8.5.
Primary NPC cultures and manipulation. Cortical progenitor cultures were prepared as described previously (Slack et al., 1998; Gloster et al., 1999; Watson et al., 2013) using cortices dissected from E12.5 embryos. Cells were seeded on polyornithine-coated (Sigma-Aldrich) plastic plates or glass coverslips. Cells were fixed in 4% paraformaldehyde for 10 min, washed in PBS, and processed for immunofluorescence. Cell viability was measured using the trypan blue dye exclusion method. Cell counts were determined with a hemacytometer.
Western blot analysis. Nuclear protein was extracted from the E16.5 telencephalon using a standard extraction kit (Thermo Scientific) and quantified using the Bradford assay. Protein (20 g) was resolved on a 6% SDS-polyacrylamide gel and transferred onto a nitrocellulose membrane (Bio-Rad). The membrane was probed with rabbit anti-p53 (1:500; Santa Cruz Biotechnology) and rabbit anti-inner centromere protein (INCENP) (1:10000; Sigma Aldrich) antibodies followed by the appropriate horseradish peroxidase-conjugated secondary antibodies (1:4000; GE Healthcare Life Sciences). The membrane was incubated in ECL before exposure to x-ray film. Densitometry analysis was performed using ImageJ software (version 1.47).
Real-time PCR. Total RNA was isolated using the RNeasy Mini kit (Qiagen). First-strand cDNA was synthesized from 1 g of total RNA using the SuperScriptTM II Reverse Transcriptase kit (Invitrogen) with deoxyribonucleotide triphosphates (dNTPs) (1 mM final concentration; GE Healthcare), porcine RNAguard (GE Healthcare), and 0.3 g random primers (GE Healthcare). Amplification was performed using a Chromo-4 Continuous Fluorescence Detector (Bio-Rad) in the presence of iQ SYBR Green supermix (Bio-Rad) and recorded using Opticon Monitor 3 software (Bio-Rad). Results were normalized to ␤-actin expression, and relative gene expression levels were calculated using GeneX software (Bio-Rad). Samples were amplified as follows: 95°C for 10 s, annealed for 20 s, 72°C for 30 s. After amplification, a melting curve was generated, and samples were resolved on a 1.5% agarose gel (75 V for 1 h) to verify amplicon purity. Primer oligomers were designed using Primer3 software (http://bioinfo.ut. ee/primer3-0.4.0/primer3/) and were obtained from Integrated DNA Technologies. Sequences are provided in Table 1 .
Chromatin immunoprecipitation. Chromatin immunoprecipitation (ChIP) experiments were performed as described previously (Kernohan et al., 2010) . Briefly, mouse forebrain tissue was dissected and processed to single-cell suspension. Cells were cross-linked in 1% formaldehyde, lysed in SDS buffer and sonicated. Immunoprecipitation was performed with a rabbit anti-CTCF antibody (Cell Signaling Technology) and a rabbit anti-p53 antibody (Santa Cruz Biotechnology). Input samples represent 1/25 of total chromatin input. ChIP products were amplified in duplicate with iQ SYBR Green Master Mix (Bio-Rad) on a Chromo-4 thermocycler under the following conditions: 95°C for 5 min, followed by 35 cycles of 95°C for 10 s, 55°C for 20 s, 72°C for 30 s, and a final Microscopy. Images were captured with a digital camera (ORCA-ER; Hamamatsu) using an inverted microscope (DMI 6000b; Leica). Openlab imaging software (PerkinElmer) was used for manual image capture, and processing was performed using Volocity software (PerkinElmer). For quantification of AC3 ϩ cells per area, AC3 ϩ cells were counted in a defined area in at least six serial cortical cryosections, and the ratio of AC3 ϩ cells to area (square millimeters) was calculated. For BrdU, SOX2, TBR2, BrdU/Ki67, TBR1, SATB2, and CTIP2 quantification, at least two serial cortical cryosections were assessed for positive cells within the indicated regions per embryo. DAPI morphology was used to bin cortex into the ventricular/subventricular zone (VZ/SVZ), intermediate zone (IZ), and cortical plate (CP).
Statistical analyses. Statistical analysis was performed using GraphPad Prism software (GraphPad Software; version 4.02), and all results are expressed as the mean Ϯ SEM. Unless indicated otherwise, p values were generated using Student's t test (unpaired, two-tailed) to compare between two independent data sets. Genotype ratios (Figs. 1A, 2A) were compared using a 2 test. To compare cell viability data (see Fig. 4E 
Results

Ctcf
Foxg1-cre mice exhibit widespread apoptosis and profound loss of telencephalic and anterior retinal tissue To study the function of CTCF in the embryonic brain, Ctcf floxed mice were intercrossed with the previously characterized Foxg1Cre mice (Hébert and McConnell, 2000; Bérubé et al., 2005; Heath et al., 2008) . Foxg1 expression is first detected between E8 and E9 in the telencephalic neuroepithelium, the basal ganglia, the olfactory bulbs, and the anterior retina (Dou et al., 1999).
Foxg1-cre
ϩ Ctcf loxP/loxP progeny resulting from this cross are Ctcf null in the anterior retina and forebrain, and will be referred to as Ctcf Foxg1-cre throughout this text. We failed to recover live Ctcf Foxg1-cre pups at birth (Fig. 1A) . At E13.5, the size of telencephalic and retinal structures was greatly diminished in mutant embryos (Fig. 1 B, C) . At E11.5, the telencephalon of mutant embryos was already noticeably smaller compared to littermate-matched controls (Fig. 1D , hatched circle). CTCF immunostaining demonstrated nuclear expression of the protein throughout the forebrain in control tissue and its absence in mutant embryos (Fig. 1E) . To determine the underlying cause of cell loss, we measured levels of proliferation and cell death in E11.5 Ctcf Foxg1-cre and control embryos. Acute (1 h) BrdU labeling of control and Ctcf Foxg1-cre embryos revealed that the percentage of cells in S phase does not vary significantly between mutant and control forebrain tissue (Fig. 1 F, G) . To measure apoptosis, we stained sections with an antibody against activated caspase-3 as a marker of cell death (Fig. 1H ) . Quantification of the results revealed a large increase in the proportion of cells undergoing apoptotic cell death in Ctcf Foxg1-cre embryos compared to littermate-matched controls (Fig. 1I ) . TUNEL also showed increased apoptosis in Ctcf Foxg1-cre embryos compared to control (Fig. 1J ). Since we already observed profound cell loss by E11.5, we wanted to analyze whether a similar mechanism was occurring earlier in this system. We observed increased AC3 immunostaining in Ctcf Foxg1-cre forebrain cryosections at E10.5, confirming that cell death occurs at this earlier time point (data not shown). We conclude that deletion of Ctcf in the mouse forebrain at approximately E8.5 causes extensive apoptosis resulting in profound loss of telencephalic and anterior retinal tissue by E13.5.
NestinCre-driven inactivation of Ctcf decreases cell survival
To determine the outcome of Ctcf deletion at a later embryonic time point in the telencephalon, we mated Ctcf flox/flox mice to the previously characterized NestinCre transgenic mice (Bérubé et al., 2005; Heath et al. 2008) . The resulting mutant is hereafter referred to as Ctcf Nes-cre for simplicity. Cre is expressed after preplate formation in this system, resulting in specific deletion of Ctcf in neural progenitor cells at approximately E11 (Bérubé et al., 2005) . We obtained the expected ratio of Ctcf Nes-cre mice at birth; however, almost all mutant pups were already dead and blue in color ( Fig. 2A) . One live Ctcf Nes-cre pup was found struggling to breathe, appeared weak, and was killed. We conclude that neonatal lethality of Ctcf Nes-cre mice is likely due to asphyxiation at birth.
We first established that the CTCF protein was lost in the basal ganglia and many cells of the cortex at E12.5 (Fig. 2B) , and expression was undetectable in the E14 Ctcf Nes-cre cortex, basal ganglia, and hippocampal hem (Fig. 2C) . To determine whether NestinCre-mediated deletion of Ctcf also induces apoptosis, we analyzed Ctcf Nes-cre forebrain cryosections at E12.5-E15.5 for evidence of AC3. At E12.5, we observed no increase in apoptotic cells in the mutant telencephalon (Fig. 2D) . However, at E14, we detected an increase in AC3 ϩ cells in the Ctcf Nes-cre cortex, basal ganglia, and hippocampal hem compared to controls (Fig. 2D) . The increase in caspase activation was also observed at E15.5 in all three forebrain regions, with the highest level of AC3 ϩ cells in the basal ganglia (Fig. 2 D, E) . Increased apoptotic cell death was also observed in vitro in primary cortical progenitor cultures established from E12.5 control and Ctcf-null telencephalon. Levels of AC3 staining were low in both control and Ctcf-null NPCs after 2 d in vitro (DIV), and we only observed a detectable increase in staining at 4 DIV (Fig. 2F ) . Together, the data suggest that when using the NestinCre driver line of mice, Ctcf deficiency does trigger the activation of caspase-mediated apoptosis in NPCs, but the effect is delayed and less severe than that observed in the Ctcf Foxg1-cre embryos, suggesting that early neuroepithelial cells are more sensitive to CTCF loss than the neuroprogenitors present slightly later in development.
Increased p53 and PUMA levels in the Ctcf-null telencephalon Both the Foxg1Cre and NestinCre models of CTCF loss exhibit increased levels of apoptosis, although the timing of onset differs between the two mutants. To investigate the molecular mechanism responsible for neuronal cell death due to CTCF loss, we assessed activation of the p53/PUMA pathway. Using Western blot analysis, we found that neuronal cell death correlated with an increase in p53 protein levels in the Ctcf Nes-cre forebrain compared to control, suggesting activation and stabilization of the protein (Fig. 3A) . We next investigated the levels of PUMA, which has been demonstrated previously to mediate NPC death downstream of p53 (Jeffers et al., 2003) . Moreover, Puma is one of the most upregulated genes in response to CTCF loss in the limb bud (Soshnikova et al., 2010) . CTCF binding sites in the Puma gene demarcate an intragenic chromatin boundary that is abolished upon CTCF knockdown in human cells, resulting in increased PUMA expression (Gomes and Espinosa, 2010b). To determine whether PUMA is involved caspase-mediated cell death in the Ctcf mutant embryos, we examined PUMA protein levels in the Ctcf Foxg1-cre and Ctcf Nes-cre mice. In the E11.5 Ctcf Foxg1-cre forebrain, we observed an increase in PUMA immunostaining compared to littermate controls, corresponding to the high levels of AC3 staining in these embryos (Fig. 3B ). In the Ctcf Nes-cre embryos, PUMA was increased in the E15.5 basal ganglia, again correlating with the highest levels of cell death (Fig. 3C) . In primary cultures, Ctcf-null NPCs exhibited increased PUMA immunostaining at 4 DIV when compared to control NPCs obtained from littermate embryos (Fig. 3D) . We also quantified Puma transcript levels by quantitative reverse-transcriptase PCR and observed a significant increase in the E16.5 Ctcf Nes-cre forebrain compared to controls (Fig. 3E ). These observations demonstrate that increased PUMA transcript and proteins levels occur as a consequence of CTCF loss in NPCs and correlate with p53 activation and the onset of caspase-mediated cell death. PUMA upregulation in the Ctcf-deficient embryonic brain could result from decreased CTCF occupancy within the Puma gene body, or because of p53-dependent activation of the gene. To investigate these possibilities further, we performed quantitative CTCF and p53 ChIP using E16.5 telencephalon isolated from control and Ctcf Nes-cre embryos (Fig. 3F--H ) . ChIP analysis confirmed CTCF binding sites found downstream of Puma exon 1 (CBS1) and exon 3 (CBS2) at the Puma gene in control tissue, similar to the binding profile of CTCF in human cancer cells ( Fig.  3G ; Gomes and Espinosa, 2010a). As expected, CTCF binding was diminished in the Ctcf Nes-cre tissue (Fig. 3G) . ChIP for p53 demonstrated specific enrichment of the protein at the Puma promoter in Ctcf Nes-cre forebrain compared to control in E16.5 tissue (Fig. 3H ) . Together, loss of CTCF in NPCs causes increased Puma transcription and protein levels due to increased p53-dependent transcriptional activation, likely combined with the loss of CTCF-dependent repression.
Deletion of Puma in a Ctcf-null context rescues cell death, but does not improve viability or brain defects at birth
To investigate whether increased PUMA levels cause cell death in the Ctcf-deficient embryonic brain, we introduced a mutant Puma allele (Bbc3 tm1Ast ) in the Ctcf loxP and NestinCre mice to generate mice that lack both Ctcf and Puma expression in the brain (hereafter referred to as Ctcf Nes-cre ;Puma Ϫ/Ϫ ). Histological analysis of E16.5 Ctcf Nes-cre cryosections showed thinning of the VZ/SVZ, hypocellularity of the intermediate zone, and a dramatic reduction in the size of the hippocampal hem (Fig. 4A) .
Ctcf
Nes-cre ;Puma Ϫ/Ϫ embryos at E16.5 showed rescue in the VZ/ SVZ thickness, as well as hippocampal size (Fig. 4A) . We confirmed these observations by partitioning the E16.5 cortex into the CP, IZ, and VZ/SVZ based on cytoarchitecture and quantifying the number of DAPI ϩ cells per region (Fig. 4 B, C) . We observed a restoration in the number of IZ cells and partial restoration in the number of VZ/SVZ cells in the Ctcf Nes-cre ; Puma Ϫ/Ϫ compared to Ctcf Nes-cre cortex (Fig. 4C ). There was no significant difference in the number of CP cells between genotypes at E16.5 (Fig. 4C) .
We performed AC3 immunostaining in E16.5 brain sections to investigate whether apoptotic cell death was rescued in the double mutant brain. AC3 ϩ cells were elevated in the Ctcf Nes-cre cortex, basal ganglia, and hippocampal hem compared to control (Fig. 4 B, D) . AC3 ϩ cells were largely localized to the ventricular zone of the neocortex, indicating that Ctcf-null proliferating cells are more susceptible to caspase-dependent cell death than differentiated cells of the cortical plate. Deletion of Puma in the Ctcf Nescre mouse was sufficient to abolish apoptotic cell death, indicating that PUMA mediates increased caspase-dependent cell death in Ctcf-null neuroprogenitor cells (Fig. 4 B, D) (Fig. 5B ). These findings indicate that although deletion of Puma prevents Ctcf-null cells from undergoing apoptosis, other factors come into play to prevent cortical size expansion in the double mutant brain.
Ctcf-null apical and oRG progenitors rescued from death by
Puma deletion fail to proliferate Given that cell death at E16.5 was rescued in the double mutant embryos but the brain hypocellularity at birth was not, we speculated that the cells rescued from apoptosis might become arrested in the cell cycle, resulting in decreased proliferation. To test this hypothesis, we performed acute BrdU labeling at E16.5 and quantified the proportion of cells in S phase by BrdU immunostaining. To compare the cortical distribution and number of NPCs in S phase, the E16.5 cortex was partitioned into the CP, IZ, and VZ/SVZ based on cytoarchitecture (Fig. 6A) (Fig. 6 A, B) . Despite ϩ cells were quantified per unit area in the cortex (Ctx), basal ganglia (BG), and hippocampal hem (H; n ϭ 3). E, Cell viability of NPC cultures was measured by trypan blue dye exclusion after 2-5 DIV (n ϭ 3). Data were analyzed by a one-way ANOVA followed by Dunnett's multiple comparisons test to determine which means were significantly different from the control. No significant difference in cell viability was found at 2 and 3 DIV ( p ϭ 0.2122 and 0.2062, respectively); however, viability was significantly different between Ctcf Nes-cre and control at 3 and 4 DIV ( p Ͻ 0.01), but not between Ctcf Nes-cre ;Puma Ϫ/Ϫ and control or Puma Ϫ/Ϫ and control ( p Ͼ 0.05). Error bars represent SEM. Original magnification: A, 100ϫ; C, 50ϫ. Scale bars: A, 200 m; B, 100 m.
substantial rescue in cellularity of the Ctcf Nes-cre ;Puma Ϫ/Ϫ cortex compared to Ctcf Nes-cre at E16.5, the proliferative capacity of progenitors was not significantly different ( Fig. 6 A, B) . Our results demonstrate that Puma deletion rescues cell death in the Ctcf-null brain, but that the rescued cells display reduced proliferative capacity.
Three NPC subtypes exist in the embryonic cortex: apical radial glia (apical progenitors), basal progenitors, and outer radial glia. Apical progenitors can be identified by their expression of SOX2 and PAX6 transcription factors (Götz et al., 1998; Tarabykin et al., 2001; BaniYaghoub et al., 2006; Shitamukai and Matsuzaki, 2012) . They undergo interkinetic nuclear migration and divide at the ventricular surface to either self-renew or differentiate into basal progenitors, outer radial glia, or cortical neurons (Shitamukai et al., 2011; Shitamukai and Matsuzaki, 2012) . Basal progenitors reside in the subventricular zone and uniquely express the T-box transcription factor TBR2 (Englund et al., 2005) . They are reported to have the potential to self-renew; however, the majority of their divisions are neurogenic (Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004) . Outer radial glia are similar to radial glia in that they have a basal process and express SOX2 and PAX6; however, oRG cells are located outside of the VZ in the outer SVZ. They are able to divide asymmetrically, producing one oRG and one neuron-committed cell with each division (Reillo et al., 2011; Shitamukai et al., 2011; Wang et al., 2011a,b; Shitamukai and Matsuzaki, 2012) . We performed acute BrdU-labeling for 1 h and coimmunostained E16.5 cortical sections with antibodies against BrdU and TBR2 or SOX2 to examine the behavior of different progenitor subtypes after loss of CTCF (Figs. 7, 8) .
The total number of TBR2 ϩ basal progenitor cells was reduced in the Ctcf Nes-cre cortex compared to control (Fig. 7 A, B) . The number of basal progenitors was restored to control levels in the Ctcf Nes-cre ;Puma Ϫ/Ϫ cortex, and most rescued cells were still able to enter S phase (Fig. 7 A, C) . Despite the correct overall number of TBR2 ϩ cells in the Ctcf Nes-cre ;Puma Ϫ/Ϫ cortex, the localization of basal progenitors appeared to be shifted apically compared to control (Fig. 7 A, B) . This is perhaps due to an inability of the rescued basal progenitors to correctly delaminate from the ventricular surface.
Quantification of SOX2 ϩ cells indicated a dramatic reduction in the number of apical progenitors and oRGs in the Ctcf Nes-cre cortex (Fig. 8 A, B) . The number of SOX2 ϩ apical progenitors was only partially rescued in the Ctcf Nes-cre ;Puma Ϫ/Ϫ cortex, indicating that CTCF may control the size of the apical progenitor pool independently of apoptosis (Fig. 8 A, B) . Conversely, oRG (SOX2 ϩ cells in the intermediate zone) numbers were restored to control levels in the Ctcf Nes-cre ;Puma Ϫ/Ϫ cortex, indicating that these cells are lost via Puma-mediated apoptotic cell death upon deletion of Ctcf (Fig. 8 A, B) . The proliferative capacity of apical progenitors (SOX2 ϩ /BrdU ϩ cells in the VZ/SVZ) was severely diminished in the Ctcf Nes-cre cortex compared to control, and was not restored in the Ctcf Nes-cre ;Puma Ϫ/Ϫ cortex ( Fig. 8 A, C) . Similarly, BrdU incorporation in the rescued Ctcf Nes-cre ;Puma Ϫ/Ϫ oRG cells was extremely low, indicating that they are likely arrested in the cell cycle and fail to correctly enter S phase (Fig. 8 A, C (Fig. 8D) .
Ctcf loss causes premature differentiation of apical progenitors Incomplete restoration of the apical progenitor population in the Ctcf Nes-cre ;Puma Ϫ/Ϫ cortex suggests that loss of CTCF leads to an apoptosis-independent reduction of these cells (Fig. 8A,B) . To identify the cause of reduced apical cell numbers, we analyzed the progenitor pool composition, cell cycle exit indices, and postmitotic projection neuron subtypes in control and Ctcf Nes-cre cortex at E14. Apical progenitors begin to produce projection neurons at approximately E11.5. At the same time, they generate neuroncommitted basal progenitors and oRG progenitors. Since the majority of basal progenitor divisions are terminal and result in the production of two neurons, this would result in increased generation of neurons at the expense of the progenitor pool (Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004) . The relative abundance of TBR2 ϩ basal progenitors was significantly increased in the E14 Ctcf Nes-cre cortex compared to control, whereas the number of SOX2 ϩ apical progenitors was not af- Fig. 9 A, B) , suggesting that differentiation of apical progenitors into basal progenitors is increased. Next, we measured the proportion of cells exiting the cell cycle by labeling embryos with BrdU for 24 h and analyzing Ki67 ϩ and BrdU ϩ cells in E14 control and Ctcf Nes-cre cortex. Cell cycle exit (BrdU ϩ Ki67 Ϫ cells/ total BrdU ϩ cells) was significantly higher in Ctcf Nes-cre cortex compared to controls (Fig. 9C,D) .
fected (
The cortical plate is established by projection neurons that organize themselves in an "inside-out" manner, such that earlyborn neurons populate deeper cortical layers (layer VI, then layer V), and late-born neurons migrate past the early-born neurons to populate the more superficial layers of the cortex (layer IV, then layer II/III; Greig et al., 2013) . Increased cell cycle exit and differentiation at E13-E14 is predicted to result in an increased number of layer VI corticothalamic projection neurons (TBR1 ϩ ), layer V subcerebral projection neurons (CTIP2 ϩ ), and callosal projection neurons (SATB2 ϩ ). We found that the relative generation of these neuronal subtypes was increased in the Ctcf Nes-cre cortex compared to control (Fig. 8E--G) , confirming premature differentiation of Ctcf-null apical progenitors, which is predicted to result in a reduced number of this progenitor pool by late neurogenesis.
Discussion
This study provides evidence that CTCF is required at very early stages of telencephalon development for the maintenance and survival of neuroprogenitor cells. We found that ablation of CTCF leads to Puma-dependent apoptosis of NPCs using two different conditional deletion strategies. Increased apoptosis correlated with p53-dependent Puma transcription, suggesting that CTCF loss results in p53 stabilization and transcriptional activation of its downstream targets. CTCF loss might also result in a more open chromatin environment at the Puma gene, facilitating p53-dependent activation of transcription and elongation of RNA polymerase II (Gomes and Espinosa, 2010a,b) . Ctcf inactivation in postmitotic cortical and hippocampal neurons does not induce apoptosis (Hirayama et al., 2012) , pointing to a specific survival role for CTCF in proliferating cells. However, CTCF loss of function may not induce apoptosis in all types of proliferating cells in vivo, as Ctcf deletion in thymocytes was shown previously to induce cell cycle arrest without induction of apoptosis (Heath et al., 2008) . It is possible that the outcome of CTCF deficiency leads to either p53-dependent cell cycle arrest or apoptosis, depending on varying cell-specific or temporal cues. This could be similar to the outcomes described upon Nbs1 (Nijmegen breakage syndrome 1/Nibrin) deletion in the CNS, which leads to p53-dependent apoptosis in the cerebellum, but causes p53-dependent cell cycle arrest in the neocortex (Li et al., 2012) .
In the present report, we demonstrate that deletion of Puma effectively rescues apoptotic cell death observed at E16.5 in the Ctcf Nes-cre brain (Fig. 4) . Despite this apparent recovery at E16.5, Figure 6 . Ctcf-deficient cells that are rescued from apoptotic death display reduced proliferative capacity. Pregnant females were subjected toa1hBrdU pulse before being killed. the double mutant brain at birth appeared hypocellular and was nearly undistinguishable histologically from the Ctcf Nes-cre brain (Fig. 5) . We showed that Ctcf Nes-cre ;Puma Ϫ/Ϫ apical and oRG progenitors that cannot activate the apoptotic pathway fail to incorporate BrdU, which might be explained by a p53-mediated cell cycle arrest. Further investigations into the mechanism underlying increased p53 levels in the Ctcf-null brain will be important to fully elucidate the role of CTCF in progenitor cell survival.
Given that oRG cells are implicated in neocortical expansion in humans, their reduced ability to proliferate in the double mutant cortex might partly explain the failure to recover cortical size at birth, and may be relevant to microcephaly caused by CTCF mutations in humans (Hansen et al., 2010; Lui et al., 2011; Reillo et al., 2011) .
A key observation is that deletion of Puma did not completely restore the number of apical cells in the Ctcf Nes-cre ;Puma Ϫ/Ϫ cor- . Ctcf-deficiency causes premature neurogenesis. A, Immunodetection of SOX2 (red) and TBR2 (green) in E14 control and Ctcf Nes-cre cortex. B, SOX2 ϩ , TBR2 ϩ , and SOX2 ϩ /TBR2 ϩ cells were quantified in 150-m-wide cortical images and expressed as a percentage of total DAPI ϩ cells (n ϭ 3). C, Pregnant female mice were subjected to a 24 h BrdU pulse before being killed. Ki67 (red) and BrdU (green) immunostaining was used to determine the percentage of cells exiting the cell cycle in control and Ctcf Nes- tex, suggesting that while a proportion of this progenitor population undergoes Puma-dependent death in the absence of CTCF, apical cells exhibit an independent defect. We found that Ctcfnull apical progenitors differentiate prematurely, causing an initial increase in the production of basal progenitors and earlyborn postmitotic neurons (Fig. 9) . However, the increased number of basal progenitors is later counteracted by a reduction of the progenitor pool from which they are derived, and exacerbated by increased levels of apoptosis. Given that CTCF colocalizes with the cohesin complex and is required for cohesin localization to specific genomic sites to influence gene expression (Parelho et al., 2008; Wendt et al., 2008) , it is conceivable that premature neurogenesis in the Ctcf Nes-cre cortex results from dysregulation of CTCF target genes.
The number of basal progenitor cells marked by TBR2 expression was completely restored in the double mutant brain, indicating that PUMA activation causes basal progenitor cell death in the absence of CTCF. Simultaneous labeling of brain sections with TBR2 and BrdU showed that rescued basal progenitors are still able to proliferate, unlike rescued apical and oRG cells. Despite the overall equivalent number of TBR2 ϩ cells in the control and double mutant cortex, several rescued basal progenitors did not move basally out of the ventricular zone, perhaps due to a defect in apical radial glia or an inability to correctly delaminate from the apical surface of the Ctcf-deficient cortex.
In summary, we demonstrated that CTCF is required in the early developing mouse brain for neuroprogenitor cell survival and that its deletion induces p53-and PUMA-dependent apoptosis. Independent from its role in promoting cell survival, CTCF is required for the correct balance of proliferative versus differentiative divisions and maintenance of the apical progenitor pool. Together, these functions of CTCF contribute to the normal development of the mammalian neocortex.
